CoChat

Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration

Open access
Zhang, Lijuan, Du, Jianhai, Justus, Sally, Hsu, Chun-Wei, Bonet-Ponce, Luis, Wu, Wen-Hsuan, Tsai, Yi-Ting, Wu, Wei-Pu, Jia, Yading, Duong, Jimmy K., Mahajan, Vinit B., Lin, Chyuan-Sheng, Wang, Shuang, Hurley, James B., Tsang, Stephen H. · 2016 · Journal of Clinical Investigation
Cited by 103

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Retinitis pigmentosa (RP) encompasses a diverse group of Mendelian disorders leading to progressive degeneration of rods and then cones. For reasons that remain unclear, diseased RP photoreceptors begin to deteriorate, eventually leading to cell death and, consequently, loss of vision. Here, we have hypothesized that RP associated with mutations in phosphodiesterase-6 (PDE6) provokes a metabolic aberration in rod cells that promotes the pathological consequences of elevated cGMP and Ca2+, which are induced by the Pde6 mutation. Inhibition of sirtuin 6 (SIRT6), a histone deacetylase repressor of glycolytic flux, reprogrammed rods into perpetual glycolysis, thereby driving the accumulation of biosynthetic intermediates, improving outer segment (OS) length, enhancing photoreceptor survival, and preserving vision. In mouse retinae lacking Sirt6, effectors of glycolytic flux were dramatically increased, leading to upregulation of key intermediates in glycolysis, TCA cycle, and glutaminolysis. Both transgenic and AAV2/8 gene therapy-mediated ablation of Sirt6 in rods provided electrophysiological and anatomic rescue of both rod and cone photoreceptors in a preclinical model of RP. Due to the extensive network of downstream effectors of Sirt6, this study motivates further research into the role that these pathways play in retinal degeneration. Because reprogramming metabolism by enhancing glycolysis is not gene specific, this strategy may be applicable to a wide range of neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci86905

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 103

Metadata

Authors
Zhang, L., Du, J., Justus, S., Hsu, C.-W., Bonet-Ponce, L., Wu, W.-H., Tsai, Y.-T., Wu, W.-P., Jia, Y., Duong, J. K., Mahajan, V. B., Lin, C.-S., Wang, S., Hurley, J. B., & Tsang, S. H.
Venue
Journal of Clinical Investigation
Published
2016-11-14
Volume
126
Issue
12
Pages
4659-4673
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2556863717
Cited by
103
References
18
FWCI
3.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. https://app.cochat.ai/papers/10.1172/jci86905
The paper
Zhang, L., Du, J., Justus, S., Hsu, C.-W., Bonet-Ponce, L., Wu, W.-H., Tsai, Y.-T., Wu, W.-P., Jia, Y., Duong, J. K., Mahajan, V. B., Lin, C.-S., Wang, S., Hurley, J. B., & Tsang, S. H. (2016). Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. Journal of Clinical Investigation. https://doi.org/10.1172/jci86905

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.